ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

LYDIA DIAZ BORRAS M.D.

202 AVE GAUTIER BENITEZ CONSOLIDATED MALL C-1-A

Caguas | Puerto Rico | 00725

(787) 258-1123

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,243Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 384

$592K Total Retail Price of All Prescriptions

Rank: 38 out of 384

394 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
1% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 13,781 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $45 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SYNTHROID 963 916 1 9
LEVOTHYROXINE SODIUM 660 591 2 11
SIMVASTATIN 635 566 3 1
PRAVASTATIN SODIUM 627 542 4 24
METFORMIN HCL 526 445 5 2
OMEPRAZOLE 514 460 6 8
AMLODIPINE BESYLATE 477 453 7 3
GABAPENTIN 394 351 8 4
LISINOPRIL 388 335 9 14
RANITIDINE HCL 382 343 10 7
ALENDRONATE SODIUM 328 284 11 20
LOSARTAN POTASSIUM 324 300 12 5
ATENOLOL 315 306 13 12
GLIMEPIRIDE 253 245 14 18
DONEPEZIL HCL 244 239 15 33
LOSARTAN-HYDROCHLOROTHIAZIDE 208 194 16 10
RAMIPRIL 186 172 17 51
ATORVASTATIN CALCIUM 186 180 17 22
METOPROLOL TARTRATE 175 137 19 15
QUINAPRIL HCL 166 150 20 110
FUROSEMIDE 162 150 21 17
HYDROCHLOROTHIAZIDE 161 124 22 16
CLOPIDOGREL 158 154 23 30
ZOLPIDEM TARTRATE 157 141 24 19
ENALAPRIL MALEATE 151 123 25 6
CRESTOR 149 110 26 45
INSULIN SYRINGE 144 120 27 46
NAMENDA 142 135 28 67
WARFARIN SODIUM 134 134 29 48
METOPROLOL SUCCINATE 133 116 30 21
GLIPIZIDE 125 98 31 27
IRBESARTAN 124 118 32 55
EVISTA 120 120 33 52
LANTUS 120 111 33 42
PLAVIX 119 117 35 32
SERTRALINE HCL 117 115 36 26
DICLOFENAC POTASSIUM 115 96 37 38
DOXAZOSIN MESYLATE 104 101 38 29
DILTIAZEM 24HR CD 104 92 38 137
NABUMETONE 102 77 40 34
PAROXETINE HCL 100 93 41 37
COUMADIN 93 93 42 100
HUMULIN N 91 70 43 57
TRAMADOL HCL-ACETAMINOPHEN 89 82 44 13
SINGULAIR 89 77 44 63
VERAPAMIL ER 88 88 46 41
DIOVAN 87 87 47 54
AVAPRO 84 84 48 87
CLOTRIMAZOLE-BETAMETHASONE 75 62 49 58
PANTOPRAZOLE SODIUM 75 69 49 39
HUMALOG MIX 75-25 74 65 51 104
LANSOPRAZOLE 74 74 51 86
ASPIRIN EC 71 59 53 31
VENLAFAXINE HCL 70 70 54 231
DIOVAN HCT 70 70 54 66
FAMOTIDINE 69 68 56 35
CARAFATE 63 61 57 178
AMLODIPINE BESYLATE-BENAZEPRIL 58 58 58 43
ISOSORBIDE MONONITRATE ER 56 56 59 28
ISOSORBIDE DINITRATE 55 55 60 118
CARVEDILOL 51 51 61 23
ZETIA 51 44 61 69
LEVOXYL 51 51 61 44
TRAMADOL HCL 50 44 64 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.